Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction
about
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and functionProstaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac HypertrophyThe contribution of prostaglandins versus prostacyclin in ventricular remodeling during heart failureAn Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and DiseasesPKA, Rap1, ERK1/2, and p90RSK mediate PGE2 and EP4 signaling in neonatal ventricular myocytes.Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice.Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusionStem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.Cytosolic phospholipase A(2)α protects against ischemia/reperfusion injury in the heart.Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2).Fractalkine neutralization improves cardiac function after myocardial infarction.Prostanoids in health and disease.Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart.The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis.Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.Knockout of the Prostaglandin E2 Receptor Subtype 3 Promotes Eccentric Cardiac Hypertrophy and Fibrosis in Mice.Inflammation leads through PGE/EP3 signaling to HDAC5/MEF2-dependent transcription in cardiac myocytes.
P2860
Q24657715-734FEB75-EA45-47C3-A9B6-CB934F9F4240Q26748618-3AA7CB16-D7A6-4FE3-8AF0-3D3554160E4EQ26830372-0867EB66-772C-49BC-953C-7A9ECFD649A2Q28067884-C239C574-F488-4FE5-8B60-F61DBB80F2B0Q33589237-BA1A7530-0369-4E98-8FBC-6E2BA9B8D527Q33656036-BE168C87-F538-457A-8C14-81E1A9E2DAB8Q34720276-665262A5-5A8C-4785-AAC9-9034CA8CB8FCQ35128063-76BB81C7-40B7-46A3-A7B9-48A63B4E02FEQ35205874-3DF22293-1823-4F87-AC80-6B2B7B6667A2Q35730075-D2A44626-926E-4744-A9A7-603275168F1AQ36390463-3063163C-2A6B-4D4A-A5DA-A48F85DC3231Q37354582-C259C1BF-39DD-4E02-859F-F3B799E0139BQ42367526-6E23A22E-8188-43BC-A6DE-62E1C00F0966Q46237716-9DB176E1-8788-4EDF-82C5-344989A3602CQ46528960-00B72951-77A4-4B61-AA9E-03D95B9F3873Q51742158-9711DA91-9659-4C63-ACCB-70F0C3269FAFQ54199502-3DC846ED-105C-4A26-A63E-F47220D64350Q55625734-41EB0AA6-E86D-477A-BACA-70D22DD14507
P2860
Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Reduced cardiac remodeling and ...... ice with myocardial infarction
@en
Reduced cardiac remodeling and ...... ice with myocardial infarction
@nl
type
label
Reduced cardiac remodeling and ...... ice with myocardial infarction
@en
Reduced cardiac remodeling and ...... ice with myocardial infarction
@nl
prefLabel
Reduced cardiac remodeling and ...... ice with myocardial infarction
@en
Reduced cardiac remodeling and ...... ice with myocardial infarction
@nl
P2093
P2860
P1433
P1476
Reduced cardiac remodeling and ...... ice with myocardial infarction
@en
P2093
Ed Shesely
Jian-Yong Qian
Margot C LaPointe
Pamela Harding
Xiao-Ping Yang
P2860
P304
P356
10.1161/HYPERTENSIONAHA.107.102590
P407
P577
2008-01-07T00:00:00Z